Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody. [electronic resource]
- Molecular cancer therapeutics Aug 2012
- 1623-6 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't